The Middle EAST Alcoholic Hepatitis Therapeutics Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 0.85 billion by 2034, registering a CAGR of 6.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of alcoholic hepatitis, increased awareness regarding liver health, and advancements in therapeutic options. The region has...